Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Decreased INPP5B expression predicts poor prognosis in lung adenocarcinoma

14 May 2022

Abstract excerpt

BACKGROUND: at the 5-position. Nevertheless, little is known about its function and cellular pathways in tumors. This study aims to investigate the potential role of INPP5B as a diagnostic and prognostic biomarker for lung adenocarcinoma (LUAD), as well as its biological functions and molecular mechanisms in LUAD. METHODS: TCGA, GEO, CTPAC, and HPA datasets were used for differential expression analysis and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to 14-3-3 protein interactions
Share to Ferroptosis and cancer prognosis
Share to Lung Cancer Treatments and Mutations

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 35568951
DOI: 10.1186/s12935-022-02609-8

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Decreased INPP5B expression predicts poor prognosis in lung adenocarcinomaPMID 35568951Read ↗

Decreased INPP5B Expression Predicts Poor Prognosis in Lung AdenocarcinomaSemantic proximity Read ↗

Prognostic Value of BIRC5 in Lung Adenocarcinoma Lacking EGFR, KRAS, and ALK Mutations by Integrated Bioinformatics AnalysisSemantic proximity Read ↗

BIRC5 as a Potential Biomarker and Therapeutic Target for Lung Adenocarcinoma: A Comprehensive Bioinformatics AnalysisSemantic proximity Read ↗

SERPINB5 is a prognostic biomarker and promotes proliferation, metastasis and epithelial‐mesenchymal transition ( EMT) in lung adenocarcinomaSemantic proximity Read ↗

PLEK2 promotes lung adenocarcinoma progression via activating the PI3K/AKT signaling pathway through SPC25 Running title: PLEK2 promotes LUAD via SPC25/PI3K/AKT axisSemantic proximity Read ↗

EXOSC5: A Novel Biomarker for Poor Prognosis in Lung AdenocarcinomaSemantic proximity Read ↗

High Expression of DLGAP5 Indicates Poor Prognosis and Immunotherapy in Lung Adenocarcinoma and Promotes Proliferation through Regulation of the Cell CycleSemantic proximity Read ↗

BIRC5 Inhibition Is Associated with Pyroptotic Cell Death via Caspase3-GSDME Pathway in Lung Adenocarcinoma CellsSemantic proximity Read ↗

PLEK2 activates the PI3K/AKT signaling pathway to drive lung adenocarcinoma progression by upregulating SPC25Semantic proximity Read ↗

SPAG5 Expression Correlated With Prognostic Implication and Immune Infiltration in Lung AdenocarcinomaSemantic proximity Read ↗

Integrated TCGA analysis implicates lncRNA CTB-193M12.5 as a prognostic factor in lung adenocarcinomaSemantic proximity Read ↗

Comprehensive analysis of hsa-miR-654-5p’s tumor-suppressing functionsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.